Sanofi | SAN - Selling And Administration Expenses


Sanofi reported EUR2.33B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.58B 316M Mar/2026
Aena EUR 170.14M 8.19M Mar/2025
Alcon AG USD 882M 19M Mar/2026
Amarin USD 18.97M 1.03M Dec/2025
Amgen USD 1.58B 354M Mar/2026
AstraZeneca USD 5.06B 455M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Biogen USD 554.3M 128.2M Mar/2026
BMW EUR 2.96B 903M Dec/2025
Bristol-Myers Squibb USD 1.62B 564M Mar/2026
Eli Lilly USD 2.93B 198M Mar/2026
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 749M 36M Mar/2026
Genmab DKK 208M 60M Dec/2025
Gilead Sciences USD 1.45B 326M Mar/2026
GlaxoSmithKline GBP 2.12B 558M Mar/2026
GRIFOLS EUR 281M 5.7M Mar/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
J&J USD 6.03B 719M Mar/2026
Lakefront Biotherapeutics EUR 35.5M 8.91M Mar/2026
Mercedes-Benz AG EUR 2.92B 11M Mar/2026
Merck EUR 1.52B 80M Mar/2026
Merck USD 2.67B 180M Mar/2026
Novartis USD 3.14B 296M Mar/2026
Novo Nordisk DKK 13.22B 4.22B Mar/2026
Orion EUR 91.9M 18.8M Mar/2026
Pfizer USD 2.92B 1.16B Mar/2026
Philips EUR 1.18B 121M Mar/2026
Recordati EUR 192.76M 5.52M Mar/2026
Regeneron Pharmaceuticals USD 647.7M 127.3M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Sanofi EUR 2.75B 455M Dec/2025
SAP EUR 2.5B 129M Mar/2026
UCB EUR 1.47B 193M Dec/2025
Vinci EUR 197M 49M Jun/2025
Volkswagen EUR 8.7B 713M Mar/2026